Stigma and Substance Use: Evidence and Myths

Presented at: Opioid Crisis 2020
C.E. Credits: P.A.C.E. CE Florida CE
Speaker
  • Associate Professor Pharmacy Practice, Wilkes University
    Biography

      Dr. Franko is a 2011 graduate of the Philadelphia College of Pharmacy.  He completed a PGY1 residency at the Wilkes-Barre Veteran’s Affairs Medical Center.  After residency he developed the first pharmacist run medication therapy management clinic focused on chronic non-cancer pain in the region at Geisinger Medical Center in Danville, PA.  Dr. Franko joined the faculty at Wilkes University in 2013 with a focus in pain management and substance use disorder.  While at Wilkes Dr. Franko authored several papers on innovative education methodologies for pain management, opioid use, and pharmacist involvement with naloxone.  He has developed a pain and addiction elective course, and a substance use disorder practice lab focused on naloxone administration and SBIRT.  He is the advisor for the Wilkes chapter of Rho Chi, Generation Rx, and the faculty liaison for SARPH, the pharmacist recovery program for Pennsylvania.  He has presented several hours of continuing education on pain and substance use disorder issues on the state and national level.  Dr. Franko serves on several local, state and national committees aimed to enhance professional and public education on substance use disorder.  Current positions include Coordinator Elect for the Pain, Palliative Care, and Addiction Special Interest Group for the American Pharmacists Association, Region Two Councilor for Rho Chi, and President-Elect of the Pennsylvania Pharmacists Association.  Dr. Franko was named a Cardinal Health Generation Rx Champion for Pennsylvania in 2018 and was the lead author for the Pennsylvania Controlled Substance Dispensing Guidelines.


    Abstract

    Breathing emergencies secondary to opioid use are the leading cause of death in Americans under the age of fifty.  Sadly, many of those who suffer from substance use disorder face a high level of stigma which negatively impacts both access to and quality of care.  Healthcare providers are primed to provide education to both patients and the public on the disease state model of substance use disorder.  This education can lead to a culture change wherein substance use disorder is viewed, as it should be, as a disease rather than a choice.  Furthermore, several misconceptions exist around the treatment of substance use disorder.  Discussing the evidence around substance use disorder treatment with patients can help reduce the negative perceptions surrounding this topic.  This presentation will review the disease state model of substance use disorder and discuss the evidence around common myths surrounding substance use disorder.

    Learning Objectives:

    1. Discuss the disease state model of substance use disorder

    2. Discuss the evidence surrounding common misconceptions regarding substance use disorder


    Show Resources
    You May Also Like
    FEB 24, 2021 10:00 AM PST
    C.E. CREDITS
    FEB 24, 2021 10:00 AM PST
    DATE: February 24, 2021 TIME: 10am PST Automated lab instruments such as liquid handlers and cell sorters are increasingly common in all types of laboratories, driving fast results for labor...
    DEC 03, 2020 4:30 PM PST
    C.E. CREDITS
    DEC 03, 2020 4:30 PM PST
    This drug development program is designed to create a family of broad-spectrum, pan-coronaviral drugs that respectively inhibit multiple key enzymes required for viral replication. By target...
    JAN 21, 2021 8:00 AM PST
    JAN 21, 2021 8:00 AM PST
    Date: January 21, 2021 Time: 8:00am (PST), 11:00am (EST) Today, critical reagent characterization is a key component in the overall workflow to establish robust ligand binding assays (e.g.,...
    NOV 18, 2020 8:00 AM PST
    C.E. CREDITS
    NOV 18, 2020 8:00 AM PST
    DATE: November 18, 2020 TIME: 08:00am PDT We develop and implement technologies to solve some of the major bottlenecks in biomedical research. In particular, we establish new imaging approac...
    NOV 05, 2020 7:00 AM PST
    C.E. CREDITS
    NOV 05, 2020 7:00 AM PST
    DATE: Date needed, 2020 TIME: Time needed Exosomes are a population of naturally occurring mobile, membrane-limited, 30 – 100 nm in diameter, extracellular vesicles containing a large...
    OCT 29, 2020 6:00 AM PDT
    C.E. CREDITS
    OCT 29, 2020 6:00 AM PDT
    Date: October 29, 2020 Time: 6:00am (PDT), 9:00am (EDT), Chronic inflammation can occur as a result of a combination of genetic predispositions and environmental factors. Epigenetic modifica...
    Loading Comments...
    Show Resources